Home - Products - Others - Other Targets - [Gln22] -β- Amyloid (1 - 40)

[Gln22] -β- Amyloid (1 - 40)

CAS No. ———

[Gln22] -β- Amyloid (1 - 40)( ——— )

Catalog No. M40696 CAS No. ———

[Gln22] -β- Amyloid (1 - 40)

Purity : >98% (HPLC)

COA

Datasheet

HNMR

HPLC

MSDS

Handing Instructions

Size	Price / USD	Stock	Quantity
25MG	Get Quote	Get Quote
50MG	Get Quote	Get Quote
100MG	Get Quote	Get Quote
200MG	Get Quote	Get Quote
500MG	Get Quote	Get Quote
1G	Get Quote	Get Quote

Get Quotation Bulk Inquiry Add to Cart

Biological Information

Product Name

[Gln22] -β- Amyloid (1 - 40)
Note

Research use only, not for human use.
Brief Description

[Gln22] -β- Amyloid (1 - 40)
Description

[Gln22] -β- Amyloid (1 - 40)
In Vitro

———
In Vivo

———
Synonyms

———
Pathway

Others
Target

Other Targets
Recptor

———
Research Area

———
Indication

———

Chemical Information

CAS Number

———
Formula Weight

4328.91
Molecular Formula

C194H296N54O57S
Purity

>98% (HPLC)
Solubility

———
SMILES

———
Chemical Name

——

Shipping & Storage Information

Storage

(-20℃)
Shipping

With Ice Pack
Stability

≥ 2 years

Reference

Calculator

Molecular Weight Calculator

Dilution Calculator

Molarity Calculator

molnova catalog

related products

Eosinophilotactic Pe...

Val-Gly-Ser-Glu (NSC 350591) is an ECF-A tetrapeptide. Val-Gly-Ser-Glu dose-dependently increases the number of human eosinophils, but not neutrophils, rosetting with complement-coated sheep erythrocytes (EAC3b).
Braylin

Braylin has anti-inflammatory, antinociceptive and immunomodulatory effects, which possibly act through the glucocorticoid receptor activation and by inhibition of the transcriptional activity of NF-κB.
diaminohydroxypropan...

Diaminohydroxypropanetetraacetic acid has been investigated for the treatment of Vascular Disease, Coronary Disease, Myocardial Ischemia, Coronary Restenosis, and Coronary Artery Disease, among others

Sign In Join Free